Acrivon Therapeutics, Inc. Common Stock
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
DEVROE ERIC officer: Chief Operating Officer
Stock Option (Right to Buy) 10,000 $1.04 $10,400
Option
DEVROE ERIC officer: Chief Operating Officer
Common Stock 10,000 $1.04 $10,400
Purchase
PERCEPTIVE ADVISORS LLC 10 percent owner
Common Stock 2,353,000 $8.5 $20,000,500
Sale
CHIONE LTD 10 percent owner
Common Stock 16 $12.93 $207
Option
HOLM-JORGENSEN RASMUS officer: Chief Financial Officer
Common Stock 9,500 $3.63 $34,485
Option
HOLM-JORGENSEN RASMUS officer: Chief Financial Officer
Stock Option (Right to Buy) 9,500 $3.63 $34,485
Sale
CHIONE LTD 10 percent owner
Common Stock 2,056 $12.14 $24,960
Sale
CHIONE LTD 10 percent owner
Common Stock 893 $12.13 $10,832
Sale
CHIONE LTD 10 percent owner
Common Stock 3,000 $12.3 $36,900
Sale
CHIONE LTD 10 percent owner
Common Stock 2,000 $12.34 $24,680
Option
DEVROE ERIC officer: Chief Operating Officer
Common Stock 9,225 $1.04 $9,594
Option
DEVROE ERIC officer: Chief Operating Officer
Stock Option (Right to Buy) 9,225 $1.04 $9,594
Option
BLUME-JENSEN PETER director, officer: President an..
Common Stock 33,605 $3.88 $130,387
Option
BLUME-JENSEN PETER director, officer: President an..
Stock Option (Right to Buy) 33,605 $3.88 $130,387
Purchase
CHIONE LTD 10 percent owner
Common Stock 400,000 $12.5 $5,000,000
Purchase
RA CAPITAL MANAGEMENT, L.P. director, 10 percent owner
Common Stock 3,389,500 $12.5 $42,368,750

Showing 1 to 16 of 16 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.